An estimated 2.5 million people in the UK rely on weight loss jabs to shed up to a fifth of their body weight, but patients who stop taking the drugs face rapid weight regain unless they follow a structured exit plan, according to recent research and health experts. A landmark study published earlier this year … Read more
The reductions come as chief executive Mike Doustdar attempts to revive the weight-loss drug pioneer’s market position amid intensifying competition and upcoming patent expirations for core blockbusters. Workforce Reductions and Cost-Cutting Measures Novo shed 13,000 jobs during the past year as part of an ongoing cost-reduction strategy, according to financial disclosures from the company. The … Read more
Erin Patterson has been approved for taxpayer-funded Ozempic injections in prison to manage rapid weight gain caused by 22 to 23 hours of daily solitary confinement, according to the Herald Sun and 7News. The Department of Corrections authorized the treatment on a clinical needs basis to reduce her risk of developing type 2 diabetes and … Read more
According to research from the Pennington Biomedical Research Center, patients taking GLP-1 receptor agonists for weight loss are experiencing unexpected medical benefits beyond fat reduction, including decreased cravings for alcohol and reduced joint inflammation. Dr. Steven Heymsfield, a professor and director of the Metabolism Body Composition Laboratory at Pennington, states that while clinical trials predicted … Read more
The Department of Veterans Affairs is launching a nationwide clinical trial to determine whether semaglutide can help treat alcohol use disorder, a condition officially diagnosed in more than 400,000 veterans nationwide, according to department data. VA researchers are studying the GLP-1 receptor agonist—marketed as Ozempic for Type 2 diabetes and Wegovy for chronic weight management—to … Read more
Popular weight loss drugs like Ozempic and Wegovy could deliver measurable economic benefits by significantly reducing employee sick leave, according to an economic study published this month by the National Bureau of Economic Research. The research found that GLP-1 medications resulted in workers taking 17 percent less long-term sick leave, translating to substantial financial savings … Read more
The rise of GLP-1 receptor agonists like Ozempic marks a transition toward a “body economy” where medical interventions, social media filters, and aesthetic procedures are increasingly viewed as mandatory for personal and professional success. According to the CCCB contemporary arts center exhibition The Cult of Beauty, this shift reinforces historical standards of perfection while rebranding … Read more
The prevalence of GLP-1 drugs for weight loss among U.S. adults has reached a record high, with 11% of the population currently using medications like Ozempic and Wegovy, according to a Gallup survey of 5,065 adults conducted between May 28 and June 5. This surge correlates with a decline in the national obesity rate, which … Read more
GLP-1 medications like Ozempic and Wegovy may increase resting heart rate and decrease heart rate variability, according to a study by WHOOP published in the American Journal of Physiology, Heart and Circulatory Physiology. While 90% of users in the study lost at least 5% of their body weight within 12 weeks, the data reveals a … Read more
Driven by the rising accessibility of GLP-1 weight-loss medications, a growing number of individuals are turning to unregulated, DIY fat-dissolving injections to contour their bodies at home. While users claim these black-market substances offer a low-cost alternative to surgical liposuction, medical professionals warn that self-administering these chemical agents poses severe health risks, including permanent skin … Read more